simendan has been researched along with Kidney Diseases in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, Z; Cui, X; Dong, X; Han, Y; Hong, Y; Huang, X; Li, Y; Mu, Y; Wang, Z; Zhang, L | 1 |
| Hou, ZQ; Hu, B; Shang, DY; Su, CY; Sun, ZX; Tan, H; Zhong, X; Zhou, Y | 1 |
| Baysal, A; Dogukan, M; Gundogus, N; Kocak, T; Koksal, C; Yanartas, M | 1 |
| Balzer, F; Braun, JP; Grubitzsch, H; Kastrup, M; Sander, M; Spies, C; Treskatsch, S; Wernecke, KD | 1 |
| Aksun, M; Bahriye Lafci, B; Gurbuz, A; Ortac, R; Ozbek, C; Tulukoglu, E; Yakut, N; Yasa, H | 1 |
2 trial(s) available for simendan and Kidney Diseases
| Article | Year |
|---|---|
Effect of levosimendan on estimated glomerular filtration rate in hospitalized patients with decompensated heart failure and renal dysfunction.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Biomarkers; Blood Pressure; Cardiotonic Agents; Chi-Square Distribution; China; Double-Blind Method; Female; Glomerular Filtration Rate; Heart Failure; Heart Rate; Hospitalization; Humans; Hydrazones; Infusions, Intravenous; Kidney Diseases; Linear Models; Male; Middle Aged; Natriuretic Peptide, Brain; Prospective Studies; Pyridazines; Simendan; Stroke Volume; Time Factors; Treatment Outcome; Urination; Ventricular Function, Left | 2013 |
Levosimendan improves renal outcome in cardiac surgery: a randomized trial.
Topics: Adult; Aged; Cardiac Surgical Procedures; Creatinine; Double-Blind Method; Female; Glomerular Filtration Rate; Humans; Hydrazones; Kidney Diseases; Male; Middle Aged; Postoperative Complications; Prospective Studies; Pyridazines; Renal Replacement Therapy; Simendan; Stroke Volume; Treatment Outcome; Vasodilator Agents | 2014 |
3 other study(ies) available for simendan and Kidney Diseases
| Article | Year |
|---|---|
Comparative Effectiveness and Safety of Milrinone and Levosimendan as Initial Inotrope Therapy in Patients With Acute Heart Failure With Renal Dysfunction.
Topics: Cardiotonic Agents; Heart Failure; Humans; Hydrazones; Kidney Diseases; Milrinone; Pyridazines; Retrospective Studies; Simendan | 2022 |
Early administration of levosimendan is associated with improved kidney function after cardiac surgery - a retrospective analysis.
Topics: Adult; Aged; Berlin; Coronary Artery Bypass; Female; Hospitals, University; Humans; Hydrazones; Intensive Care Units; Intraoperative Period; Kidney Diseases; Male; Postoperative Complications; Pyridazines; Retrospective Studies; Simendan; Vasodilator Agents | 2014 |
The influence of levosimendan and iloprost on renal ischemia-reperfusion: an experimental study.
Topics: Animals; Atrophy; Disease Models, Animal; Female; Hydrazones; Iloprost; Kidney; Kidney Diseases; Lipid Peroxidation; Male; Malondialdehyde; Necrosis; Protective Agents; Pyridazines; Rabbits; Reperfusion Injury; Simendan | 2008 |